BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19876562)

  • 21. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
    Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
    J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis C virus among users attending a voluntary testing centre in Rio Grande, southern Brazil: predictive factors and hepatitis C virus genotypes.
    Germano FN; dos Santos CA; Honscha G; Strasburg A; Gabbi B; Mendoza-Sassi RA; Soares EA; Seuánez HN; Soares MA; Martínez AM
    Int J STD AIDS; 2010 Jul; 21(7):466-71. PubMed ID: 20852195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.
    Matheï C; Wollants E; Verbeeck J; Van Ranst M; Robaeys G; Van Damme P; Buntinx F
    Eur J Clin Microbiol Infect Dis; 2005 Aug; 24(8):514-22. PubMed ID: 16133411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil.
    Silva LK; Silva MB; Rodart IF; Lopes GB; Costa FQ; Melo ME; Gusmão E; Reis MG
    Braz J Med Biol Res; 2006 May; 39(5):595-602. PubMed ID: 16648896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
    Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
    J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus infection in Brazilian long-distance truck drivers.
    Freitas NR; Teles SA; Matos MA; Lopes CL; Reis NR; Espírito-Santo MP; Lampe E; Martins RM
    Virol J; 2010 Aug; 7():205. PubMed ID: 20799961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus infection among drug addicts in Italy.
    Stroffolini T; D'Egidio PF; Aceti A; Filippini P; Puoti M; Leonardi C; Almasio PL;
    J Med Virol; 2012 Oct; 84(10):1608-12. PubMed ID: 22930509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and risk factors of HCV infection in Poland.
    Flisiak R; Halota W; Horban A; Juszczyk J; Pawlowska M; Simon K
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1213-7. PubMed ID: 22002000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
    Matheï C; Buntinx F; Van Damme P
    J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of hepatitis C virus infection in quilombo remnant communities in Central Brazil.
    Reis NR; Motta-Castro AR; Silva AM; Teles SA; Yoshida CF; Martins RM
    Rev Inst Med Trop Sao Paulo; 2008; 50(6):359-60. PubMed ID: 19082380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological, epidemiological and molecular aspects of hepatitis C virus infection in a population from Londrina, PR, Brazil, 2001-2002.
    Vogler IH; Nishiya A; Morimoto HK; Reiche EM; Bortoliero AL; Matsuo T; Sabino EC; Vaz AJ
    Rev Inst Med Trop Sao Paulo; 2004; 46(6):303-8. PubMed ID: 15654474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatitis C infection among intravenous drug users in Shanghai.
    Tao YL; Tang YF; Qiu JP; Cai XF; Shen XT; Wang YX; Zhao XT
    World J Gastroenterol; 2013 Aug; 19(32):5320-5. PubMed ID: 23983436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region.
    Oliveira-Filho AB; Santos FJA; Silva FQ; Raiol NC; Costa CCS; Piauiense JNF; Martins LC; Cardoso YMN; Di Miceli JFF; Resque RL; Silva-Oliveira GC; Pinheiro LML; Machado LFA; Pinho JRR; Lemos JAR; Kupek E; Fischer B
    BMC Infect Dis; 2019 Jul; 19(1):634. PubMed ID: 31315569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
    Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
    J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
    Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.
    Bokharaei-Salim F; Keyvani H; Esghaei M; Zare-Karizi S; Dermenaki-Farahani SS; Hesami-Zadeh K; Fakhim S
    J Med Virol; 2016 Nov; 88(11):1960-6. PubMed ID: 27463051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.
    Apichartpiyakul C; Apichartpiyakul N; Urwijitaroon Y; Gray J; Natpratan C; Katayama Y; Fujii M; Hotta H
    Jpn J Infect Dis; 1999 Jun; 52(3):121-3. PubMed ID: 10507992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B and C infection among drug abusers in Nepal.
    Shrestha SM; Shrestha DM; Gafney TE; Maharjan KG; Tsuda F; Okamoto H
    Trop Gastroenterol; 1996; 17(4):212-3. PubMed ID: 9094859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.